Financials
- Market Capitalization 32.38 M
- Employee 25
- Founded 2000
- CEO Sandesh Seth
- Website www.actiniumpharma.com
- Headquarter Delaware, United States
- FIGI BBG000RQZ245
- Industry Biyoteknoloji
Toplam gelir
Net kar
Temel hisse başına kazanç (Temel EPS)
Toplam borç
Serbest nakit akışı
Nakit ve eşdeğerleri
Fiyat/kazanç oranı
2.8
Fiyat/satışlar oranı
0.88
Related tickers
| # | Ad | Fiyat | 24s % | 7g % | 1A % | 1Y % | Piyasa Değeri | Son 7 Gün | |
|---|---|---|---|---|---|---|---|---|---|
| 4396 | KYNB Kyntra Bio, Inc. - Common Stock | 8.33 USD | -1.88% | +5.18% | +17.99% | -12.41% | 33.73 M USD | ||
| 4401 | ACTU Actuate Therapeutics, Inc. - Common stock | 1.44 USD | +5.11% | -15.29% | +28.57% | -64.71% | 34.58 M USD | ||
| 4420 | CNTX Context Therapeutics Inc. - Common Stock | 0.35 USD | -2.78% | -10.26% | -44.44% | -57.32% | 32.16 M USD | ||
| 4429 | BRNS Barinthus Biotherapeutics plc - American Depositary Shares | 0.76 USD | +5.56% | +8.57% | +33.33% | -39.68% | 31.05 M USD |